Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease

NCT03764605 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

ADPKD

Interventions

DRUG: Metformin
DRUG: Tolvaptan

Sponsor

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari